PIK3CA Mutation as Potential Poor Prognostic Marker in Asian Female Breast Cancer Patients Who Received Adjuvant Chemotherapy.
Yoon-Ah ChoSeung Yeon KoYong Joon SuhSanghwa KimJung Ho ParkHye-Rim ParkJinwon SeoHyo Geun ChoiHo Suk KangHyun LimHa Young ParkMi Jung KwonPublished in: Current oncology (Toronto, Ont.) (2022)
mutation together with c-Met or dMMR/MSI status might be relevant to poor prognosis in BC subsets, especially in Asian women.